Apr 2, 2025
by Suyeon Jang
Laplace Partners has recently successfully established its third investment fund, specifically designed to invest in Capsbio, a promising biotech venture.
Capsbio is dedicated to developing next-generation biopharmaceuticals by leveraging its innovative technology. Laplace Partners looks forward to contributing to the advancement of the biotechnology sector alongside Capsbio.
We will soon provide more detailed updates about Capsbio, including the background and rationale behind our investment. Please stay tuned!
Back to News